Rationale for individualizing haemophilia care.


Owing to the heterogeneity in the clinical phenotype of haemophilia A and B, it is now recognized that disease severity (based on factor VIII/IX activity) may no longer be the most appropriate guide for treatment and that a 'one-size-fits-all' approach is unlikely to achieve optimal therapy. Based on the present literature and consensus views of a group of… (More)
DOI: 10.1097/MBC.0000000000000225


3 Figures and Tables

Cite this paper

@article{Srensen2015RationaleFI, title={Rationale for individualizing haemophilia care.}, author={Benny S\orensen and Guenter Auerswald and Gary Benson and Ivo V Elezovi{\'c} and Markus Felder and Thierry Lambert and Massimo Morfini and E Remor and Peter Salaj and Elena Santagostino and Silva Zupan{\vc}i{\'c} {\vS}alek and Rolf C R Ljung}, journal={Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis}, year={2015}, volume={26 8}, pages={849-57} }